# The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）

> **NCT06828718** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hebei Medical University Fourth Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Esophageal Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06828718
- **Lead sponsor:** Hebei Medical University Fourth Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-02-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06828718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06828718, "The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06828718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*